CEDARS-SINAI MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1902-01-01

Employees: 12K

Market Cap: -

Website: http://www.cedars-sinai.org

Clinical Trials

Calibration of MR and PET-MR Imaging Protocols at RIC

Not Applicable

Withdrawn

Conditions: Coronary Artery Disease
Cancer

Interventions: Other: MR-only imaging on Biograph mMR scanner
Other: PET-MR imaging on Biograph mMR scanner
Other: MR imaging on the Siemens Vida 3T MR scanner

First Posted Date: 2014-09-25

Last Posted Date: 2024-08-21

Lead Sponsor: Cedars-Sinai Medical Center

Registration Number: NCT02249520

Locations: 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States

Pilot of AbStats /AEGIS System for Detecting Motility Abnormalities

Completed

Conditions: Motility Disorders

First Posted Date: 2014-09-08

Last Posted Date: 2018-01-29

Lead Sponsor: Cedars-Sinai Medical Center

Target Recruit Count: 10

Registration Number: NCT02233270

Locations: 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States

Liraglutide Actions on the Liver: Effects on Glucose Phosphorylation

Phase 4

Withdrawn

Conditions: Type 2 Diabetes

Interventions: Drug: Liraglutide

First Posted Date: 2014-07-23

Last Posted Date: 2019-09-30

Lead Sponsor: Cedars-Sinai Medical Center

Registration Number: NCT02198209

Locations: 🇺🇸
Cedars Sinai Medical Center, Los Angeles, California, United States

Cut Your Pressure Too: The Altadena Barbershop Blood Pressure Study, Phase 2 (Intervention Pilot Study)

Not Applicable

Completed

Conditions: Hypertension

Interventions: Other: barbershop-based BP measurement

First Posted Date: 2014-07-23

Last Posted Date: 2014-07-23

Lead Sponsor: Cedars-Sinai Medical Center

Target Recruit Count: 14

Registration Number: NCT02198144

Locations: 🇺🇸
Cedars-Sinail Medical Center, Los Angeles, California, United States

Identification Genetic, Immunologic and Microbial Markers of Hirschsprung Associated Enterocolitis in Children With Hirschsprung Disease

Recruiting

Conditions: Hirschsprung Disease
Enterocolitis

First Posted Date: 2014-07-18

Last Posted Date: 2016-08-12

Lead Sponsor: Cedars-Sinai Medical Center

Target Recruit Count: 400

Registration Number: NCT02193685

Locations: 🇺🇸
Cedars-Sinai Medical Center 8723 Alden Drive, Suite 240, Los Angeles, California, United States

Oral Nifedipine Versus Oral Labetalol

Not Applicable

Completed

Conditions: Severe Postpartum Hypertension

Interventions: Drug: Nifedipine
Drug: Labetalol

First Posted Date: 2014-06-20

Last Posted Date: 2017-12-13

Lead Sponsor: Cedars-Sinai Medical Center

Target Recruit Count: 50

Registration Number: NCT02168309

Locations: 🇺🇸
Cedars Sinai Medical Center, Los Angeles, California, United States

3D Multi-Contrast Atherosclerosis Characterization of the Carotid Artery

Completed

Conditions: Carotid Artery Disease

Interventions: Other: MRI with/without contrast

First Posted Date: 2014-06-13

Last Posted Date: 2024-02-15

Lead Sponsor: Cedars-Sinai Medical Center

Target Recruit Count: 134

Registration Number: NCT02163408

Locations: 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States

Effects of Sodium Nitrate on Blood Flow in Becker Muscular Dystrophy

Phase 2

Completed

Conditions: Becker Muscular Dystrophy

Interventions: Procedure: Increased exercise intensity
Dietary Supplement: Placebo
Dietary Supplement: Sodium Nitrate
Dietary Supplement: Sodium Nitrate - double dose

First Posted Date: 2014-05-28

Last Posted Date: 2020-01-14

Lead Sponsor: Cedars-Sinai Medical Center

Target Recruit Count: 19

Registration Number: NCT02147639

Locations: 🇺🇸
Cedars-Sinai Heart Institute, Los Angeles, California, United States

Effects of Hookah Smoking on Blood Flow to the Heart, Muscle and Skin

Not Applicable

Completed

Conditions: Hookah Smoking

Interventions: Other: Hookah smoking

First Posted Date: 2014-05-28

Last Posted Date: 2020-01-13

Lead Sponsor: Cedars-Sinai Medical Center

Target Recruit Count: 42

Registration Number: NCT02147665

Locations: 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States

C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI

Phase 1

Completed

Conditions: Delayed Graft Function
Kidney Failure
Ischemic Reperfusion Injury
End Stage Renal Disease

Interventions: Drug: C1 Esterase Inhibitor
Drug: Placebo

First Posted Date: 2014-05-09

Last Posted Date: 2018-06-25

Lead Sponsor: Cedars-Sinai Medical Center

Target Recruit Count: 70

Registration Number: NCT02134314

Locations: 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy